Author

Kelley A. Fedler

Observed names: Kelley A Fedler, Kelley Fedler

ORCID: 0000-0001-8717-2259

Observed ORCID: 0000-0001-8717-2259

OpenAlex ID: A5031490617

Omiganan Pentahydrochloride (MBI 226), a Topical 12-Amino-Acid Cationic Peptide: Spectrum of Antimicrobial Activity and Measurements of Bactericidal Activity

2004 · Helio S. Sader, Kelley A. Fedler, et al. · Antimicrobial Agents and Chemotherapy · 143

Assessment of pathogen frequency and resistance patterns among pediatric patient isolates: Report from the 2004 SENTRY Antimicrobial Surveillance Program on 3 continents

2006 · Kelley A. Fedler, Douglas J. Biedenbach, et al. · Diagnostic Microbiology and Infectious Disease · 106

Cefiderocol MIC quality control ranges in iron-depleted cation-adjusted Mueller–Hinton broth using a CLSI M23-A4 multi-laboratory study design

2017 · Michael D. Huband, Akinobu Ito, et al. · Diagnostic Microbiology and Infectious Disease · 39

Development of Broth Microdilution MIC and Disk Diffusion Antimicrobial Susceptibility Test Quality Control Ranges for the Combination of Cefepime and the Novel β-Lactamase Inhibitor Enmetazobactam

2019 · Adam Belley, Michael D. Huband, et al. · Journal of Clinical Microbiology · 18

Activity of gatifloxacin tested against isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (North America, 1998–2003)

2006 · Kelley A. Fedler, Ronald N. Jones, et al. · Diagnostic Microbiology and Infectious Disease · 17

Multicenter Investigation of Gepotidacin (GSK2140944) Agar Dilution Quality Control Determinations for Neisseria gonorrhoeae ATCC 49226

2016 · Ronald N. Jones, Kelley A. Fedler, et al. · Antimicrobial Agents and Chemotherapy · 15

Determination of MIC and disk diffusion quality control guidelines for meropenem–vaborbactam, a novel carbapenem/boronic acid β-lactamase inhibitor combination

2017 · Erik Munson, Michael D. Huband, et al. · Diagnostic Microbiology and Infectious Disease · 9

Surveillance of omadacycline against 35,000 bacterial clinical isolates from the United States (2019-2023)

2025 · Michael D. Huband, Kelley A. Fedler, et al. · Diagnostic Microbiology and Infectious Disease · 8

In vitro activity of omadacycline against bacterial isolates from bone/joint infections and rare pathogens in the SENTRY antimicrobial surveillance program (2015–2023)

2025 · Michael D. Huband, Paul R. Rhomberg, et al. · Journal of Global Antimicrobial Resistance · 6

Determination of MIC Quality Control Ranges for Ceftibuten-Avibactam (Fixed 4 μg/mL), a Novel β-Lactam/β-Lactamase Inhibitor Combination

2023 · Michael D. Huband, Kelley A. Fedler, et al. · Journal of Clinical Microbiology · 6

Correlation between Broth Microdilution and Disk Diffusion Results when Testing Ceftazidime-Avibactam against a Challenge Collection of Enterobacterales Isolates: Results from a Multilaboratory Study

2020 · Helio S. Sader, Paul R. Rhomberg, et al. · Journal of Clinical Microbiology · 6

In vitro activity of sulopenem and comparator agents against US Enterobacterales clinical isolates collected during the SENTRY antimicrobial surveillance program in 2023

2025 · Steven I. Aronin, Michael D. Huband, et al. · Journal of Global Antimicrobial Resistance · 5

Use of voriconazole to predict susceptibility and resistance to isavuconazole for Aspergillus fumigatus using CLSI methods and interpretive criteria

2024 · Marisa L. Winkler, Paul R. Rhomberg, et al. · Journal of Clinical Microbiology · 4

P-1333. Activity of Zosurabalpin and Comparator Antimicrobial Agents Tested Against Acinetobacter baumannii-calcoaceticus complex (ABC) Isolates Collected Worldwide in 2024

2026 · Joshua Maher, Mariana Castanheira, et al. · Open Forum Infectious Diseases · 3

PDF

In vitro activity of KHP-3757 (a novel LpxC inhibitor) and comparator agents against recent and molecularly characterized Pseudomonas aeruginosa isolates from a global surveillance program (2017–2018)

2020 · Michael D. Huband, Jill M. Lindley, et al. · Diagnostic Microbiology and Infectious Disease · 3

Activity of manogepix and comparator antifungal agents against uncommon filamentous fungal isolates collected in a global surveillance program

2026 · Marisa L. Winkler, Abby Klauer, et al. · Microbiology Spectrum

Activity of Isavuconazole and Comparator Agents Against Pediatric Isolates From Invasive Fungal Infections

2026 · Marisa L Winkler, Paul Rhomberg, et al. · Journal of the Pediatric Infectious Diseases Society

P-1340. Activity of Delafloxacin and Comparator Agents Against Bacterial Isolates From Patients with Diabetic Foot Infection in the United States and Europe (2017–2023)

2026 · Michael D Huband, Marisa Winkler, et al. · Open Forum Infectious Diseases

P-1196. Geographic distribution, MIC testing, and susceptibility rates of Candida auris isolates collected in the United States since 2014

2026 · Marisa Winkler, John Kimbrough, et al. · Open Forum Infectious Diseases

PDF

P-1208. In Vitro Activity of Sulopenem and Comparator Agents Against U.S. Enterobacterales Clinical Isolates, SENTRY Antimicrobial Surveillance Program, 2023

2026 · Steven I Aronin, Michael D Huband, et al. · Open Forum Infectious Diseases

P-1168. Activity of Isavuconazole and Comparator Agents against Pediatric Fungal Isolates Collected from 2017–2023 in a Global Surveillance Program

2025 · Marisa Winkler, Paul Rhomberg, et al. · Open Forum Infectious Diseases

PDF

P-411. Activity of Omadacycline Against 35,000 Bacterial Clinical Isolates and Resistant Organism Subsets from Patients in the United States (2019–2023)

2025 · Michael D Huband, Kelley A Fedler, et al. · Open Forum Infectious Diseases

2757. Activity of meropenem-vaborbactam tested against Burkholderia species isolates

2023 · Mariana Castanheira, Dee Shortridge, et al. · Open Forum Infectious Diseases

PDF

1292. Activity of Omadacycline and Comparators Against 876 Bacterial Clinical Isolates from Patients with Bone and Joint Infections in the United States and Europe (2015–2022)

2023 · Michael D Huband, Michael A Pfaller, et al. · Open Forum Infectious Diseases

PDF

Works count: 24

Citation count: 388

H-index: 8

I10-index: 6